74
Participants
Start Date
June 4, 2018
Primary Completion Date
September 2, 2021
Study Completion Date
September 2, 2021
Memorial Sloan Kettering Cancer Center, New York
University of Michigan Comprehensive Cancer Center, Ann Arbor
MD Anderson Cancer Center, Houston
University of Colorado Cancer Center, Denver
Dana Farber Cancer Institute, Boston
Lead Sponsor
Collaborators (1)
Analysis Group, Inc.
INDUSTRY
Epizyme, Inc.
INDUSTRY